newsfilter
← Latest News
PR Newswire·

Compugen to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...